Peter M Hecht - Net Worth and Insider Trading
Peter M Hecht Net Worth
The estimated net worth of Peter M Hecht is at least $22 Million dollars as of 2024-11-06. Peter M Hecht is the CEO of Ironwood Pharmaceuticals Inc and owns about 4,731,916 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $21 Million. Peter M Hecht is also the CEO of Cyclerion Therapeutics Inc and owns about 102,458 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $283,675. Details can be seen in Peter M Hecht's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter M Hecht has not made any transactions after 2021-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter M Hecht
Peter M Hecht Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter M Hecht owns 2 companies in total, including Cyclerion Therapeutics Inc (CYCN) , and Ironwood Pharmaceuticals Inc (IRWD) .
Click here to see the complete history of Peter M Hecht’s form 4 insider trades.
Insider Ownership Summary of Peter M Hecht
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2021-06-03 | director & Chief Executive Officer |
| IRWD | Ironwood Pharmaceuticals Inc | 2019-01-25 | director & Chief Executive Officer |
Peter M Hecht Latest Holdings Summary
Peter M Hecht currently owns a total of 2 stocks. Among these stocks, Peter M Hecht owns 4,731,916 shares of Ironwood Pharmaceuticals Inc (IRWD) as of January 25, 2019, with a value of $21 Million and a weighting of 98.68%. Peter M Hecht also owns 102,458 shares of Cyclerion Therapeutics Inc (CYCN) as of June 3, 2021, with a value of $283,675 and a weighting of 1.32%.
Latest Holdings of Peter M Hecht
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2019-01-25 | 4,731,916 | 4.49 | 21,246,303 |
| CYCN | Cyclerion Therapeutics Inc | 2021-06-03 | 102,458 | 2.77 | 283,675 |
Holding Weightings of Peter M Hecht
Peter M Hecht Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter M Hecht has made a total of 0 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 89,551 shares on January 25, 2019, which brought Peter M Hecht around $1 Million.
According to the SEC Form 4 filings, Peter M Hecht has made a total of 3 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cyclerion Therapeutics Inc is the acquisition of 41,159 shares on June 3, 2021, which cost Peter M Hecht around $3 Million.
Insider Trading History of Peter M Hecht
- 1
Peter M Hecht Trading Performance
GuruFocus tracks the stock performance after each of Peter M Hecht's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter M Hecht is 16.91%. GuruFocus also compares Peter M Hecht's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter M Hecht within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter M Hecht's insider trading performs compared to the benchmark.
Performance of Peter M Hecht
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.82 | | | | | |
| Relative Return to S&P 500(%) | 15.47 | | | | | |
Peter M Hecht Ownership Network
Ownership Network List of Peter M Hecht
Ownership Network Relation of Peter M Hecht
Peter M Hecht Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Peter M Hecht is the director & Chief Executive Officer of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , 10 percent owner Slate Path Capital Lp , and Chief Financial Officer Anjeza Gjino .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
Over the past 18 months, Peter M Hecht made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Peter M Hecht Mailing Address
Above is the net worth, insider trading, and ownership report for Peter M Hecht. You might contact Peter M Hecht via mailing address: C/o Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
